POTS (Postural Orthostatic Tachycardia Syndrome) is a multisystem disorder characterized by the abnormal autonomic response to an upright posture, causing orthostatic intolerance and excessive tachycardia without hypotension. Recent reports suggest that a significant percentage of COVID-19 survivors develop POTS within 6 to 8 months of infection. Prominent symptoms of POTS include fatigue, orthostatic intolerance, tachycardia, and cognitive impairment. The exact mechanisms of post-COVID-19 POTS are unclear. Still, different hypotheses have been given, including autoantibody production against autonomic nerve fibers, direct toxic effects of SARS-CoV-2, or sympathetic nervous system stimulation secondary to infection. Physicians should have a high suspicion of POTS in COVID-19 survival when presented with symptoms of autonomic dysfunction and should conduct diagnostic tests like the Tilt table and others to confirm it. The management of COVID-19-related POTS requires a comprehensive approach. Most patients respond to initial non-pharmacological options, but when the symptoms become more severe and they do not respond to the non-pharmacological approach, pharmacological options are considered. We have limited understanding and knowledge of post-COVID-19 POTS, and further research is warranted to improve our understanding and formulate a better management plan.
Cureus Overlapping Myocarditis and Postural Orthostatic Tachycardia Syndrome After COVID-19 Messenger RNA Vaccination: A Case Report
Perspective Chapter: Cardiovascular Post-Acute COVID-19 Syndrome – Definition, Clinical Scenarios, Diagnosis, and Management
Autonomic dysfunction and postural orthostatic tachycardia syndrome in post-acute COVID-19 syndrome
Postural orthostatic tachycardia syndrome - Wikipedia
Characterizing long COVID in an international cohort: 7 months of symptoms and their impact - eClinicalMedicine
Acute and Post-Acute COVID-19 Cardiovascular Complications: A Comprehensive Review
Blog - Physical Therapy Portland
Cureus, COVID-19 Induced Postural Orthostatic Tachycardia Syndrome (POTS): A Review
Understanding and Managing Postural Orthostatic Tachycardia Syndrome
Post-COVID dysautonomias: what we know and (mainly) what we don't know
Understanding and Managing Postural Orthostatic Tachycardia Syndrome
Frontiers Postural orthostatic tachycardia syndrome and other related dysautonomic disorders after SARS-CoV-2 infection and after COVID-19 messenger RNA vaccination
POTS-associated Conditions and Management Strategies